NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in LLY — ELI LILLY & Co
CIK 921739
PHILADELPHIA, PA
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$631,142,517
+$497,947,865 QoQ
Shares Held
526,202
+263.4% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#120
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $1,744,000,343 across 11 Drug Manufacturers - General names. LLY ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
526,202 | $631,142,517 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,768,793 | $476,149,307 | |
| 3 | ABBV |
AbbVie Inc.
|
821,326 | $206,678,474 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,055,302 | $135,606,307 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,776,782 | $102,378,178 | |
| 6 | PFE |
Pfizer Inc
|
3,457,889 | $83,265,967 | |
| 7 | JNJ |
Johnson & Johnson
|
263,443 | $66,906,618 | |
| 8 | AMGN |
Amgen Inc
|
72,087 | $26,104,144 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $631,142,517 | 526,202 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $133,194,652 | 144,813 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $157,411,618 | 146,473 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||